These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

965 related articles for article (PubMed ID: 26460009)

  • 1. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases.
    Weeber F; van de Wetering M; Hoogstraat M; Dijkstra KK; Krijgsman O; Kuilman T; Gadellaa-van Hooijdonk CG; van der Velden DL; Peeper DS; Cuppen EP; Vries RG; Clevers H; Voest EE
    Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13308-11. PubMed ID: 26460009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell-derived organoids and their application for medical research and patient treatment.
    Bartfeld S; Clevers H
    J Mol Med (Berl); 2017 Jul; 95(7):729-738. PubMed ID: 28391362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer.
    Cristobal A; van den Toorn HWP; van de Wetering M; Clevers H; Heck AJR; Mohammed S
    Cell Rep; 2017 Jan; 18(1):263-274. PubMed ID: 28052255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying cellular heterogeneity and drug sensitivity in colorectal cancer using organoid technology.
    Sasaki N; Clevers H
    Curr Opin Genet Dev; 2018 Oct; 52():117-122. PubMed ID: 30261425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity.
    Bruun J; Kryeziu K; Eide PW; Moosavi SH; Eilertsen IA; Langerud J; Røsok B; Totland MZ; Brunsell TH; Pellinen T; Saarela J; Bergsland CH; Palmer HG; Brudvik KW; Guren T; Dienstmann R; Guren MG; Nesbakken A; Bjørnbeth BA; Sveen A; Lothe RA
    Clin Cancer Res; 2020 Aug; 26(15):4107-4119. PubMed ID: 32299813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics].
    Tostivint V; Racaud-Sultan C; Roumiguié M; Soulié M; Gamé X; Beauval JB
    Presse Med; 2017 Oct; 46(10):954-965. PubMed ID: 28967525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
    Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
    Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for establishing organoids from human ovarian cancer biopsies.
    Maenhoudt N; Vankelecom H
    STAR Protoc; 2021 Jun; 2(2):100429. PubMed ID: 33870230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy.
    Narasimhan V; Wright JA; Churchill M; Wang T; Rosati R; Lannagan TRM; Vrbanac L; Richardson AB; Kobayashi H; Price T; Tye GXY; Marker J; Hewett PJ; Flood MP; Pereira S; Whitney GA; Michael M; Tie J; Mukherjee S; Grandori C; Heriot AG; Worthley DL; Ramsay RG; Woods SL
    Clin Cancer Res; 2020 Jul; 26(14):3662-3670. PubMed ID: 32376656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of organoids for personalized medicine.
    Perkhofer L; Frappart PO; Müller M; Kleger A
    Per Med; 2018 Nov; 15(6):461-465. PubMed ID: 30418092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanically and chemically defined hydrogel matrices for patient-derived colorectal tumor organoid culture.
    Ng S; Tan WJ; Pek MMX; Tan MH; Kurisawa M
    Biomaterials; 2019 Oct; 219():119400. PubMed ID: 31398570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective derivation of a living organoid biobank of colorectal cancer patients.
    van de Wetering M; Francies HE; Francis JM; Bounova G; Iorio F; Pronk A; van Houdt W; van Gorp J; Taylor-Weiner A; Kester L; McLaren-Douglas A; Blokker J; Jaksani S; Bartfeld S; Volckman R; van Sluis P; Li VS; Seepo S; Sekhar Pedamallu C; Cibulskis K; Carter SL; McKenna A; Lawrence MS; Lichtenstein L; Stewart C; Koster J; Versteeg R; van Oudenaarden A; Saez-Rodriguez J; Vries RG; Getz G; Wessels L; Stratton MR; McDermott U; Meyerson M; Garnett MJ; Clevers H
    Cell; 2015 May; 161(4):933-45. PubMed ID: 25957691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study.
    Jensen LH; Rogatto SR; Lindebjerg J; Havelund B; Abildgaard C; do Canto LM; Vagn-Hansen C; Dam C; Rafaelsen S; Hansen TF
    J Exp Clin Cancer Res; 2023 May; 42(1):115. PubMed ID: 37143108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoid in colorectal cancer: progress and challenges.
    Ji DB; Wu AW
    Chin Med J (Engl); 2020 Aug; 133(16):1971-1977. PubMed ID: 32826461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards personalized induction therapy for esophageal adenocarcinoma: organoids derived from endoscopic biopsy recapitulate the pre-treatment tumor.
    Derouet MF; Allen J; Wilson GW; Ng C; Radulovich N; Kalimuthu S; Tsao MS; Darling GE; Yeung JC
    Sci Rep; 2020 Sep; 10(1):14514. PubMed ID: 32884042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays.
    Brandenberg N; Hoehnel S; Kuttler F; Homicsko K; Ceroni C; Ringel T; Gjorevski N; Schwank G; Coukos G; Turcatti G; Lutolf MP
    Nat Biomed Eng; 2020 Sep; 4(9):863-874. PubMed ID: 32514094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
    Sachs N; de Ligt J; Kopper O; Gogola E; Bounova G; Weeber F; Balgobind AV; Wind K; Gracanin A; Begthel H; Korving J; van Boxtel R; Duarte AA; Lelieveld D; van Hoeck A; Ernst RF; Blokzijl F; Nijman IJ; Hoogstraat M; van de Ven M; Egan DA; Zinzalla V; Moll J; Boj SF; Voest EE; Wessels L; van Diest PJ; Rottenberg S; Vries RGJ; Cuppen E; Clevers H
    Cell; 2018 Jan; 172(1-2):373-386.e10. PubMed ID: 29224780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Cell Transcriptomics Reveals Heterogeneity and Drug Response of Human Colorectal Cancer Organoids.
    Chen KY; Srinivasan T; Lin C; Tung KL; Gao Z; Hsu DS; Lipkin SM; Shen X
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():2378-2381. PubMed ID: 30440885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.